Last reviewed · How we verify

NCT05082038

Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants

Status unknown NA Last updated 13 November 2023
What this trial tests

NA trial testing Mandibular partial rehabilitation with IF Tapared implants in Edentulous Jaw in 18 participants. Status unknown.

Timeline
23 September 2021
Primary endpoint
1 May 2025
30 July 2025

Quick facts

Lead sponsorNeodent
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment18
Start date23 September 2021
Primary completion1 May 2025
Estimated completion30 July 2025
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Neodent

Who can join

18 and older, any sex, with Edentulous Jaw. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nuvo Tapered IF (internal hexagonal connection) and CF (conical connextion) Implants were designed for the the oral functional rehabilitation using dental implants, allowing for treatment of patients with different bone qualities. The aim of the study is to confirm the long-term safety and clinical performance of implants and abutments of Nuvo IF and CF in daily dental practice setting, by means of prospective collection of clinical data in randomized clinical trial using these devices. Devices will be used , according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant loading.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Edentulous Jaw

Currently open trials in the same condition.

Other Neodent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05082038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing